GL1X · GenesisL1 explorer

Research workbench

Scfv abvance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery

Analyse Scfv abvance: increasing our knowledge of antibody structural space to enable… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EHX
Type
protein
Length
228 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Scfv abvance: increasing our knowledge of antibody structural space to enable faster and…
Pockets
2 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BScfv abvance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discoveryprotein2284% helix, 52% strand—

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.320.7323empty
2740.320.7417empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6EHX · scFv AbVance: increasing our knowledge of antibody structural space to enable faster and… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.